HOPE for Rational Statin Allocation for Primary Prevention: A Coronary Artery Calcium Picture Is Worth 1000 Words

Mihaylova, 2012, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, Lancet, 380, 581, 10.1016/S0140-6736(12)60367-5 Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [published corrections appear in Lancet. 2005;366(9494):1358 and Lancet. 2008;371(9630):2084], Lancet, 366, 1267 Grundy, 2019, J Am Col Cardiol, 73, e285, 10.1016/j.jacc.2018.11.003 Lloyd-Jones, 2019, J Am Coll Cardiol, 73, 3153, 10.1016/j.jacc.2018.11.005 Yeboah, 2015, Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines, Circulation, 132, 916, 10.1161/CIRCULATIONAHA.115.016846 Yeboah, 2016, Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment, J Am Coll Cardiol, 67, 139, 10.1016/j.jacc.2015.10.058 Nasir, 2015, J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 Waheed, 2016, Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: the St Francis Heart Study, Atherosclerosis, 255, 193, 10.1016/j.atherosclerosis.2016.09.060 Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 Mahabadi, 2017, Heinz Nixdorf Recall Study Investigators. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines, JACC Cardiovasc Imaging, 10, 143, 10.1016/j.jcmg.2016.03.022 Shah, 2017, Subclinical atherosclerosis, statin eligibility, and outcomes in African American individuals: the Jackson Heart Study, JAMA Cardiol, 2, 644, 10.1001/jamacardio.2017.0944 Mortensen, 2019, Negative risk markers for cardiovascular events in the elderly, J Am Coll Cardiol, 74, 1, 10.1016/j.jacc.2019.04.049 Yusuf, 2016, Cholesterol lowering in intermediate-risk persons without cardiovascular disease, N Engl J Med, 374, 2021, 10.1056/NEJMoa1600176 Shaw, 2009, Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study, J Am Coll Cardiol, 54, 1258, 10.1016/j.jacc.2009.07.018 MacMahon, 2017, Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017, Radiology, 284, 228, 10.1148/radiol.2017161659 Munden, 2018, Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A white paper of the ACR Incidental Findings Committee, J Am Coll Radiol, 15, 1087, 10.1016/j.jacr.2018.04.029 Hecht, 2017, J Cardiovasc Comput Tomogr, 11, 74, 10.1016/j.jcct.2016.11.003 Hendrick, 2010, Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology Imaging Network digital mammographic imaging screening trial, AJR Am J Roentgenol, 194, 362, 10.2214/AJR.08.2114 Miglioretti, 2016, Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study, Ann Intern Med, 164, 205, 10.7326/M15-1241 DeSantis, 2017, Breast cancer statistics, 2017, racial disparity in mortality by state, CA Cancer J Clin, 67, 439, 10.3322/caac.21412 Wilkins, 2012, Lifetime risk and years lived free of total cardiovascular disease, JAMA, 308, 1795, 10.1001/jama.2012.14312 2019 Mortensen Pandya, 2015, Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease [published correction appears in JAMA. 2015;314(15):1647], JAMA, 314, 142, 10.1001/jama.2015.6822 Kohli-Lynch Byrne, 2019, Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews, BMJ Open, 9, e023085, 10.1136/bmjopen-2018-023085 Byrne, 2019, Statins for primary prevention of cardiovascular disease, BMJ, 367, l5674, 10.1136/bmj.l5674